Literature DB >> 21864196

Reporter gene HEK 293 cells and WNT/Frizzled fusion proteins as tools to study WNT signaling pathways.

Larisa Ring1, Iris Peröbner, Marisa Karow, Marianne Jochum, Peter Neth, Alexander Faussner.   

Abstract

WNT/Frizzled receptor (FZD) signaling pathways are pivotal for physiological and pathophysiological processes. In humans, the complexity of WNT/FZD signaling is based on 19 WNTs, 10 FZDs and at least two (co)receptors (LRP5/6) mediating supposably four different signaling cascades. The detailed investigation of the specific function of the different initiating components is primarily hampered by the lack of most WNT proteins in a purified form. Therefore, we constructed and examined a chimeric protein of WNT3a and FZD4 as a suitable approach to overcome this obstacle for future studies of the specificity of other WNT/FZD combinations. Furthermore, we produced four different reporter HEK 293 cell lines to quantify the induced activation of the proposed signaling cascades, the β-catenin-, the NFAT-, the AP-1- and the CRE-regulated pathways. The chimera WNT3aFZD4 efficiently induced β-catenin-mediated luciferase activity. This activity was increased 40-fold compared with basal when LRP6 was stably cotransfected, proving that the chimera WNT3aFZD4 can also interact efficiently with LRP6. Our results demonstrate that the approach of using reporter gene cell lines in combination with WNT/FZD chimeras is efficient to study the β-catenin-mediated pathway and should also allow clarifying the specificity of WNT/FZD combinations in the activation of the other pathways.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21864196     DOI: 10.1515/BC.2011.164

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  6 in total

1.  Melanoma-Derived Wnt5a Promotes Local Dendritic-Cell Expression of IDO and Immunotolerance: Opportunities for Pharmacologic Enhancement of Immunotherapy.

Authors:  Alisha Holtzhausen; Fei Zhao; Kathy S Evans; Masahito Tsutsui; Ciriana Orabona; Douglas S Tyler; Brent A Hanks
Journal:  Cancer Immunol Res       Date:  2015-06-03       Impact factor: 11.151

2.  Vascular smooth muscle LRP6 limits arteriosclerotic calcification in diabetic LDLR-/- mice by restraining noncanonical Wnt signals.

Authors:  Su-Li Cheng; Bindu Ramachandran; Abraham Behrmann; Jian-Su Shao; Megan Mead; Carolyn Smith; Karen Krchma; Yoanna Bello Arredondo; Attila Kovacs; Kapil Kapoor; Laurence M Brill; Ranjan Perera; Bart O Williams; Dwight A Towler
Journal:  Circ Res       Date:  2015-06-01       Impact factor: 17.367

3.  Pharmacological Wnt ligand inhibition overcomes key tumor-mediated resistance pathways to anti-PD-1 immunotherapy.

Authors:  Nicholas C DeVito; Michael Sturdivant; Balamayooran Thievanthiran; Christine Xiao; Michael P Plebanek; April K S Salama; Georgia M Beasley; Alisha Holtzhausen; Veronica Novotny-Diermayr; John H Strickler; Brent A Hanks
Journal:  Cell Rep       Date:  2021-05-04       Impact factor: 9.423

4.  The nuclear factor κB inhibitor (E)-2-fluoro-4'-methoxystilbene inhibits firefly luciferase.

Authors:  Albert Braeuning; Silvia Vetter
Journal:  Biosci Rep       Date:  2012-12       Impact factor: 3.840

5.  Immobilization of Wnt Fragment Peptides on Magnetic Nanoparticles or Synthetic Surfaces Regulate Wnt Signaling Kinetics.

Authors:  Bin Hu; Michael Rotherham; Neil Farrow; Paul Roach; Jon Dobson; Alicia J El Haj
Journal:  Int J Mol Sci       Date:  2022-09-05       Impact factor: 6.208

6.  A new fluorescence-based reporter gene vector as a tool for analyzing and fishing cells with activated wnt signaling pathway.

Authors:  Johanna Apfel; Patricia Reischmann; Oliver Müller
Journal:  ISRN Oncol       Date:  2013-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.